InflaRx IFRX
NASDAQ IFRX
$1.55 +0.01 (+0.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Change in Receivables (2024)

Updated

InflaRx's Change in Receivables was $1.15 million in Q2 2026, compared with -$21,678 a year earlier.

Analysis

InflaRx (IFRX) Change in Receivables (2024) Analysis & Trends

On a trailing twelve-month basis, InflaRx's Change in Receivables was $2.56 trillion through Jun 30, 2026, up 130.1% year-over-year; for FY2025, it came in at $2.49 trillion, up 123.4% from FY2024.

  • In earlier years, Change in Receivables was $1.11 trillion in FY2024 (-86.8%) and $8.42 trillion in FY2023.
  • Quarterly Change in Receivables has moved between -$409,381 (Q1 2025) and $2.56 trillion (Q4 2025) over five years.
  • Per Business Quant data, IFRX's Change in Receivables in the three quarters before Q2 2026 was -$190,409 (Q1 2026), $2.56 trillion (Q4 2025) and -$75,224 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 InflaRx 104.63 Mn -228.98 Mn 2.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -70,114.73
Jun 30, 2024 12,400.36
Mar 31, 2024 -38,285.56
API Access

InflaRx Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=IFRX&period=max&api_key=YOUR_API_KEY